PHARMA
Alzheimer's Treatment Divide: Are We Chasing the Wrong Target?
The recent survey of neurologists regarding new Alzheimer's treatments reveals a significant divide in the medical community. While these new drugs target amyloid plaques in the brain, there's growing concern that this approach may be too little, too late in the fight against Alzheimer's